5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Long-term efficacy of dasatinib in chronic-phase CML: Results from the phase I trial (CA180002)
    Meeting Abstract

    Cortes, J.; Sawyers, C. L.; Kantarjian, H. M.; Shah, N. P.; Paquette, R.; Paliwal, P.; Bleickardt, E.; Talpaz, M.
    Blood (2007)

    Fulltext@MSK | Save
  • Evaluation of the sequenom MassARRAY system for detecting mutations in the EGFRand KRAS genes in 174 lung adenocarcinomas
    Meeting Abstract

    Chitale, D. A.; Broderick, S. R.; Ladanyi, M.
    Journal of Molecular Diagnostics (2007)

    Fulltext@MSK | Save
  • Phase II trial of a chemotherapy-only regimen of busulfan, melphalan, fludarabine and R-ATG followed by allogeneic T-cell depleted (TCD) hematopoietic stem cell transplants (HSCT) for the treatment of myeloid malignancies
    Meeting Abstract

    Boulad, F.; Jakubowski, A.; Papadopoulos, E.; Hsu, K. C.; Perales, M. A.; Van Den Brink, M.; Young, J. W.; Chiu, M.; Kernan, N. A.; Prockop, S. E.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
    Meeting Abstract

    Bean, J.; Brennan, C.; Shih, J. Y.; Riely, G.; Viale, A.; Wang, L.; Chitale, D.; Motoi, N.; Szoke, J.; Broderick, S.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Adult Xp11 translocation renal cell carcinoma (RCC): Expanded clinical, pathologic, and genetic spectrum
    Meeting Abstract

    Argani, P.; Olgac, S.; Tickoo, S.; Goldfischer, M.; Moch, H.; Chan, D. Y.; Eble, J. N.; Bonsib, S.; Jimeno, M.; Lloreta, J.; more...
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • Adult Xp11 translocation renal cell carcinoma (RCC): Expanded clinical, pathologic, and genetic spectrum
    Meeting Abstract

    Argani, P.; Olgac, S.; Tickoo, S.; Goldfischer, M.; Moch, H.; Chan, D. Y.; Eble, J. N.; Bonsib, S.; Jimeno, M.; Lloreta, J.; more...
    Modern Pathology (2007)

    Fulltext@MSK | Save
  • EWS-CREB1 is the predominant gene fusion in so-called angiomatoid fibrous histiocytoma (AFH)
    Meeting Abstract

    Antonescu, C. R.; Dal Cin, P.; Nafa, K.; Teot, L. A.; Fletcher, C. D. M.; Ladanyi, M.
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • EWS-CREB1 is the predominant gene fusion in so-called angiomatoid fibrous histiocytoma (AFH)
    Meeting Abstract

    Antonescu, C.; Dal Cin, P.; Nafa, K.; Teot, L. A.; Fletcher, C.; Ladanyi, M.
    Modern Pathology (2007)

    Fulltext@MSK | Save
  • Donor killer 1G-like receptor haplotype is associated with lower relapse in chronic myelogenous leukemia patients undergoing allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Abarghoui, F.; Pinto-Agnello, C.; Gooley, T.; Senitzer, D.; Malkki, M.; Dupont, B.; Petersdorf, E.; Hsu, K.
    Biology of Blood and Marrow Transplantation (2007)

    Fulltext@MSK | Save